Antiarteriosclerotic N-(mercaptoacyl)-histidines
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsTadashi Fujita, Masayuki Oya, Toshio Watanabe, Takehisa Chiba
Life of this patent
Estimating the term…
Abstract
This invention relates to the compound: N-(mercaptoacyl)-histidine represented by the following formula wherein n is 1 or 2, having activity as an antiarteriosclerosis agent, the intermediate thereof and a process for manufacture thereof. ##STR1##
Claims9
N-(mercaptoacyl)-histidine represented by the formula ##STR6## wherein n is an integer from 1 to 2.
N-(mercaptoacetyl)-histidine.
N-(3-mercaptopropionyl)-histidine.
N-(benzoylmercaptoacyl)-histidine represented by the formula (V) wherein n is 1 or 2 ##STR7##
An antiarteriosclerosis composition containing an effective amount of N-(mercaptoacyl)-histidine represented by formula (I) wherein n is 1 or 2 ##STR8## and a pharmacetical carrier.
Dependencies are inferred from the claim text.